Alphamab Oncology Market Cap

Alphamab Oncology has a market cap or net worth of 7.76 billion as of March 9, 2026. Its market cap has increased by 115.55% in one year.

Market Cap

7.76B

Enterprise Value

6.26B

Revenue

861.24M

Ranking

n/a

PE Ratio

30.94

Stock Price

8.59

Market Cap Chart

Since December 12, 2019, Alphamab Oncology's market cap has decreased from 12.11B to 7.76B, a decrease of -35.93%. That is a compound annual growth rate of -6.89%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	7.60B	-19.90%
Dec 31, 2025	9.49B	181.80%
Dec 31, 2024	3.37B	-47.42%
Dec 29, 2023	6.41B	-36.87%
Dec 30, 2022	10.15B	-20.36%
Dec 31, 2021	12.74B	-16.28%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CK Life Sciences Int'l., (Holdings)	7.59B
Lepu Biopharma	7.92B
Abbisko Cayman	7.99B
CARsgen Therapeutics Holdings	6.04B
CStone Pharmaceuticals	9.79B
Shanghai Haohai Biological Technology	9.96B
HBM Holdings	10.08B
Ocumension Therapeutics	5.65B

Market Cap Rankings